Article

Sentinel lymph node mapping with type-II quantum dots.

Division of Hematology/Oncology, Department of Radiology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
Methods in Molecular Biology (Impact Factor: 1.29). 02/2007; 374:147-59. DOI: 10.1385/1-59745-369-2:147
Source: PubMed

ABSTRACT Sentinel lymph node (SLN) mapping is an important cancer surgery during which the first lymph node draining the site of a tumor is identified, resected, and analyzed for the presence or absence of malignant cells. Fluorescent semiconductor nanocrystals (quantum dots [QDs]) of the appropriate size, charge, and emission wavelength permit this surgery to be performed rapidly, with high sensitivity and under complete image guidance. We describe the materials and methods necessary for the production and characterization of type-II near-infrared fluorescent QDs, which have been optimized for SLN mapping. They contain a CdTe core, CdSe shell, and a highly anionic, oligomeric phosphine organic coating. We also describe how to utilize such QDs in animal model systems of SLN mapping.

0 Bookmarks
 · 
155 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Quantum dots (Qdots) have become ubiquitous in biomedical research due to their excellent brightness, photostability, monodispersity, and fluorescent yield. Furthermore, they have become increasingly useful as imaging agents which are valuable for answering molecular questions in living subjects. However, little is currently known about how nanoparticles such as Qdots interact at the microscale within the vasculature and tumor microenvironments in living subjects. In order to further our understanding of the dynamic processes involved in Qdot targeting in the intact tumor, we developed an in vivo binding assay to visualize and fully elucidate this approach using a variety of animal models and tumor types. We employed argine-glycine-aspartic acid (RGD) peptides to specifically target the alphavbeta3 integrins which are expressed on the surface of endothelial cells comprising newly formed or forming blood vessels; RGD peptides were conjugated to the Qdot surface. Exploiting intravital microscopy with subcellular-level resolution, we directly observed and recorded the binding of nanoparticle conjugates in two different murine models, using three different tumor cell lines. Using this generalizable approach, we learned that RGD-qdots unexpectedly bind to tumor blood vessels in all models tested only as aggregates rather than individually. Understanding these issues on the microscale using such techniques will provide a platform for the rational design of molecularly-targeted nanoparticles including Qdots. This is critical for nanoparticles to become a valuable research tool with the potential to become clinically valuable imaging and therapeutic agents, particularly for ensuring regulatory approval of such nanoparticles.
    Proceedings of SPIE - The International Society for Optical Engineering 02/2009; · 0.20 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: CdS, ZnS, Ga2S3, CaS and Cs2S quantum dots (QDs) were generated in the amylopectin (Ap) matrix. They all emitted a light between 460 (ZnS) and 475 (CdS) nm. Sizes of Ga2S3 and CdS QDs were 7-9 nm and 5-7 nm, respectively. Single ZnS QDs had 6-7 nm but they readily aggregated. The CaS and Cs2S appeared mainly as 30 to 100 nm aggregates. There were no significant interactions between QDs and the Ap matrix. Presented method appeared unsuitable for the generation of CaS and Cs2S QDs as they as well as their substrates [Ca(NO3)2] hydrolyzed. Calcium compounds formed complexes with Ap and alkaline solution from CsOH could produce cesium salts of Ap as well as cause oxidation of Ap.
    Journal of Alloys and Compounds 09/2014; volume 607(ISSN: 0925-8388):39–43. · 2.73 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Cancer is a major threat to public health in the 21st century because it is one of the leading causes of death worldwide. The mechanisms of carcinogenesis, cancer invasion, and metastasis remain unclear. Thus, the development of a novel approach for cancer detection is urgent, and real-time monitoring is crucial in revealing its underlying biological mechanisms. With the optical and chemical advantages of quantum dots (QDs), QD-based nanotechnology is helpful in constructing a biomedical imaging platform for cancer behavior study. This review mainly focuses on the application of QD-based nanotechnology in cancer cell imaging and tumor microenvironment studies both in vivo and in vitro, as well as the remaining issues and future perspectives.
    Cancer biology & medicine. 09/2012; 9(3):151-163.

Full-text (2 Sources)

Download
53 Downloads
Available from
May 27, 2014